Author pages are created from data sourced from our academic publisher partnerships and public sources.
Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis.
INTRODUCTION Changes in atrioventricular (AV) conduction and need for permanent pacemaker (PPM) are a recognized complication after open aortic valve replacement. We hypothesized that the need for… Expand
Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic-Corevalve bioprosthesis.
AIMS Prosthesis-patient mismatch (P-PM) is an important determinant of morbidity and mortality following open aortic valve replacement. The aims of this study were to report its incidence and… Expand
Early regression of left ventricular wall thickness following percutaneous aortic valve replacement with the CoreValve bioprosthesis.
- H. Jilaihawi, M. Jeilan, T. Spyt, D. Chin, E. Logtens, J. Kovac
- The Journal of invasive cardiology
- 1 April 2009
BACKGROUND/AIMS Severe aortic stenosis (AS) is associated with hypertrophy of the left ventricle (LVH), which is linked to adverse clinical outcomes. To date, the effects of the novel technology of… Expand
Comparison of complete versus incomplete stent frame expansion after transcatheter aortic valve implantation with Medtronic CoreValve bioprosthesis.
We sought to determine the significance of incomplete stent frame expansion after transcatheter aortic valve implantation with the Medtronic-CoreValve device. Incomplete coronary stent expansion is a… Expand
Intestinal angiodysplasia and aortic valve stenosis: let's not close the book on this association.
- P. Mishra, J. Kovac, J. D. de Caestecker, Graham Fancourt, E. Logtens, T. Spyt
- European journal of cardio-thoracic surgery…
- 1 April 2009
The association between gastrointestinal (GI) bleeding due to angiodysplasia of the large intestine and calcific aortic stenosis (AS) has been a matter of debate. Recent studies suggest that this… Expand
Percutaneous aortic valve replacement in patients with challenging aortoiliofemoral access
- H. Jilaihawi, T. Spyt, D. Chin, E. Logtens, Jean-Claude Laborde, J. Kovac
- Catheterization and cardiovascular interventions…
- 15 November 2008
Percutaneous aortic valve replacement (PAVR) offers considerable promise in treating high risk patients with aortic valve disease. Two devices are currently clinically available for transfemoral… Expand
Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial)
- U. Benedetto, D. Altman, +261 authors L. Manzano-Espinosa
- Journal of the American Heart Association
- 3 March 2018
Background There is still uncertainty about the safety of aprotinin for coronary artery bypass graft surgery. The ART (Arterial Revascularization Trial) was designed to compare survival after… Expand
Abstract 4512: One-Year Clinical Outcome after Percutaneous Aortic Valve Implantation
Percutaneous aortic valve replacement (pAVR) with the CoreValve self expanding bioprosthesis in severe calcific aortic stenosis results in improvement of symptoms of heart failure and early…
Background: The early effects on left ventricular wall thickness and symptoms of heart failure in patients with severe degenerative aortic stenosis following percutaneous aortic valve replacementwith… Expand
218. A new approach to the treatment of mitral regurgitation caused by mural leaflet pathologies
Objective To assess immediate postoperative outcomes of mitral valve reconstruction with MitroFix device (Biointegral Surgical, Mississauga, ON, Canada) in patients with extensive prolapse of the… Expand